Michael Christoph Kreissl (Michael Kreissl, Michael C Kreissl)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 34

Top Topics

Prognostic Factors

Neuroendocrine Tumors

Top Venues

Diagnostics (Basel, Switzerland)

Journal of clinical medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Vahé Barsegian, Daniel Möckel, Sebastian Buehler, Stefan P Müller, Michael Christoph Kreissl, Patrick Ostheim, Peter A Horn, Monika Lindemann
Lymphocyte Function at Baseline Could Be a New Predictor of Tumor Burden following Six Cycles of Radium-223 Therapy in Patients with Metastasized, Castration-Resistant Prostate Cancer. Cancers 16 (5) (2024)
Manuela Petersen, Simone A Schenke, Franziska Veit, Rainer Görges, Philipp Seifert, Michael Zimny, Roland Siegfried Croner, Michael Christoph Kreissl, Alexander R Stahl
Thyroid Imaging Reporting and Data Systems: Applicability of the "Taller than Wide" Criterium in Primary/Secondary Care Units and the Role of Thyroid Scintigraphy. Journal of clinical medicine 13 (2) (2024)
Manuela Petersen, Simone A Schenke, Franziska Veit, Rainer Görges, Philipp Seifert, Michael Zimny, Roland Siegfried Croner, Michael Christoph Kreissl, Alexander R Stahl
Thyroid Imaging Reporting and Data Systems: Applicability of the "Taller than Wide" Criterium in Primary/Secondary Care Units and the Role of Thyroid Scintigraphy. Journal of clinical medicine 13 (2) (2024)
Oliver S Grosser, Martin Volk, Marilena Georgiades, Daniel Punzet, Bahaa Alsawalhi, Dennis Kupitz, Jazan Omari, Heiko Wissel, Michael Christoph Kreissl, Georg Rose, Maciej Pech
Effect of Spectral Filtering and Segmental X-ray Tube Current Switch-Off on Interventionalist's Scatter Exposure during CT Fluoroscopy. Bioengineering (Basel, Switzerland) 11 (8) (2024)
Oliver S Grosser, Martin Volk, Marilena Georgiades, Daniel Punzet, Bahaa Alsawalhi, Dennis Kupitz, Jazan Omari, Heiko Wissel, Michael Christoph Kreissl, Georg Rose, Maciej Pech
Effect of Spectral Filtering and Segmental X-ray Tube Current Switch-Off on Interventionalist's Scatter Exposure during CT Fluoroscopy. Bioengineering (Basel, Switzerland) 11 (8) (2024)
Vahé Barsegian, Daniel Möckel, Sebastian Buehler, Stefan P Müller, Michael Christoph Kreissl, Patrick Ostheim, Peter A Horn, Monika Lindemann
Lymphocyte Function at Baseline Could Be a New Predictor of Tumor Burden following Six Cycles of Radium-223 Therapy in Patients with Metastasized, Castration-Resistant Prostate Cancer. Cancers 16 (5) (2024)
Philipp Genseke, Christoph Ferdinand Wielenberg, Jens Schreiber, Eva Luecke, Steffen Frese, Thorsten Walles, Michael Christoph Kreissl
Prospective Evaluation of Quantitative F-18-FDG-PET/CT for Pre-Operative Thoracic Lymph Node Staging in Patients with Lung Cancer as a Target for Computer-Aided Diagnosis. Diagnostics (Basel, Switzerland) 13 (7) (2023)
Ken Kudura, Nando Ritz, Arnoud J Templeton, Tim Kutzker, Martin H K Hoffmann, Kwadwo Antwi, Daniel Rudolf Zwahlen, Michael Christoph Kreissl, Robert Foerster
An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data. Cancers 15 (22) (2023)
Ken Kudura, Nando Ritz, Arnoud J Templeton, Marc Kissling, Tim Kutzker, Robert Foerster, Martin H K Hoffmann, Kwadwo Antwi, Michael Christoph Kreissl
Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival. Cancers 15 (5) (2023)
Friederike Eilsberger, Michael Christoph Kreissl, Christoph Reiners, Adrien Holzgreve, Markus Luster, Andreas Pfestroff
Application of the American Thyroid Association Risk Assessment in Patients with Differentiated Thyroid Carcinoma in a German Population. Biomedicines 11 (3) (2023)
Petra Petranović Ovčariček, Alfredo Campenni, Bart de Keizer, Desiree Deandreis, Michael Christoph Kreissl, Alexis Vrachimis, Murat Tuncel, Luca M Giovanella
Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer. Cancers 15 (17) (2023)
Linnea Højer Wang, Markus Wehland, Petra M Wise, Manfred Infanger, Daniela Grimm, Michael Christoph Kreissl
Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect. International journal of molecular sciences 24 (3) (2023)
Akram N Al-Ibraheem, Ula Al-Rasheed, Noor Mashhadani, Ahmed Saad Abdlkadir, Dhuha Ali Al-Adhami, Saad Ruzzeh, Feras Istatieh, Areen Mansour, Basem Hamdan, Reem Kheetan, Marwa Al-Shatti, Issa Mohamad, Malik E Juweid, Areej Abu Sheikha, Kamal Al-Rabi, Gerasimos P Sykiotis, Michael Christoph Kreissl, Taleb Ismael, Iyad Sultan, Hikmat Abdel-Razeq
Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients. Cancers 15 (16) (2023)
Friederike Eilsberger, Michael Christoph Kreissl, Christoph Reiners, Adrien Holzgreve, Markus Luster, Andreas Pfestroff
Application of the American Thyroid Association Risk Assessment in Patients with Differentiated Thyroid Carcinoma in a German Population. Biomedicines 11 (3) (2023)
Michael Christoph Kreissl
Comments on Study of "Performance of 18F-DCFPyL PET/CT in Primary Prostate Cancer Diagnosis, Gleason Grading and D'Amico Classification: A Radiomics-Based Study". Phenomics (Cham, Switzerland) 3 (6) (2023)
Michael Christoph Kreissl
Comments on Study of "Performance of 18F-DCFPyL PET/CT in Primary Prostate Cancer Diagnosis, Gleason Grading and D'Amico Classification: A Radiomics-Based Study". Phenomics (Cham, Switzerland) 3 (6) (2023)
Ken Kudura, Nando Ritz, Arnoud J Templeton, Tim Kutzker, Robert Foerster, Kwadwo Antwi, Michael Christoph Kreissl, Martin H K Hoffmann
Predictive Value of Total Metabolic Tumor Burden Prior to Treatment in NSCLC Patients Treated with Immune Checkpoint Inhibition. Journal of clinical medicine 12 (11) (2023)
Linnea Højer Wang, Markus Wehland, Petra M Wise, Manfred Infanger, Daniela Grimm, Michael Christoph Kreissl
Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect. International journal of molecular sciences 24 (3) (2023)
Linnea Højer Wang, Markus Wehland, Petra M Wise, Manfred Infanger, Daniela Grimm, Michael Christoph Kreissl
Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect. International journal of molecular sciences 24 (3) (2023)
Elmer Jeto Gomes Ataide, Mathews S Jabaraj, Simone Schenke, Manuela Petersen, Sarvar Haghghi, Jan Wuestemann, Alfredo Illanes, Michael Friebe, Michael Christoph Kreissl
Thyroid Nodule Detection and Region Estimation in Ultrasound Images: A Comparison between Physicians and an Automated Decision Support System Approach. Diagnostics (Basel, Switzerland) 13 (18) (2023)
Ken Kudura, Nando Ritz, Arnoud J Templeton, Marc Kissling, Tim Kutzker, Robert Foerster, Martin H K Hoffmann, Kwadwo Antwi, Michael Christoph Kreissl
Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival. Cancers 15 (5) (2023)
Manuela Petersen, Simone A Schenke, Michael Zimny, Rainer Görges, Michael Grunert, Daniel Groener, Philipp Seifert, Peter E Stömmer, Michael Christoph Kreissl, Alexander R Stahl, null On Behalf Of The German Tirads Study Group
Introducing a Pole Concept for Nodule Growth in the Thyroid Gland: Taller-than-Wide Shape, Frequency, Location and Risk of Malignancy of Thyroid Nodules in an Area with Iodine Deficiency. Journal of clinical medicine 11 (9) (2022)
Amina Banda, Bastiaan M Privé, Youssra Allach, Maike J M Uijen, Steffie M B Peters, Cato C Loeff, Martin Gotthardt, Constantijn H J Muselaers, J Alfred Witjes, Inge M van Oort, J P Michiel Sedelaar, Harm Westdorp, Niven Mehra, Fadi Khreish, Samer Ezziddin, Amir Sabet, Michael Christoph Kreissl, Thomas Winkens, Philipp Seifert, Marcel J R Janssen, Willemijn A M van Gemert, James Nagarajah
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study. Cancers 15 (1) (2022)
Ken Kudura, Nando Ritz, Tim Kutzker, Martin H K Hoffmann, Arnoud J Templeton, Robert Foerster, Michael Christoph Kreissl, Kwadwo Antwi
Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors. Cancers 14 (24) (2022)
Amina Banda, Bastiaan M Privé, Youssra Allach, Maike J M Uijen, Steffie M B Peters, Cato C Loeff, Martin Gotthardt, Constantijn H J Muselaers, J Alfred Witjes, Inge M van Oort, J P Michiel Sedelaar, Harm Westdorp, Niven Mehra, Fadi Khreish, Samer Ezziddin, Amir Sabet, Michael Christoph Kreissl, Thomas Winkens, Philipp Seifert, Marcel J R Janssen, Willemijn A M van Gemert, James Nagarajah
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study. Cancers 15 (1) (2022)
Ken Kudura, Nando Ritz, Tim Kutzker, Martin H K Hoffmann, Arnoud J Templeton, Robert Foerster, Michael Christoph Kreissl, Kwadwo Antwi
Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors. Cancers 14 (24) (2022)
Simone Agnes Schenke, Alfredo Campenní, Murat Tuncel, Gianluca Bottoni, Sait Sağer, Tatjana Bogovic Crncic, Damir Rozic, Rainer Görges, Pınar Pelin Ozcan, Daniel Groener, Hubertus Hautzel, Rigobert Klett, Michael Christoph Kreissl, Luca M Giovanella
Diagnostic Performance of 99m Tc-Methoxy-Isobuty-Isonitrile (MIBI) for Risk Stratification of Hypofunctioning Thyroid Nodules: A European Multicenter Study. Diagnostics (Basel, Switzerland) 12 (6) (2022)
Ken Kudura, Nando Ritz, Tim Kutzker, Martin H K Hoffmann, Arnoud J Templeton, Robert Foerster, Michael Christoph Kreissl, Kwadwo Antwi
Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors. Cancers 14 (24) (2022)
Amina Banda, Bastiaan M Privé, Youssra Allach, Maike J M Uijen, Steffie M B Peters, Cato C Loeff, Martin Gotthardt, Constantijn H J Muselaers, J Alfred Witjes, Inge M van Oort, J P Michiel Sedelaar, Harm Westdorp, Niven Mehra, Fadi Khreish, Samer Ezziddin, Amir Sabet, Michael Christoph Kreissl, Thomas Winkens, Philipp Seifert, Marcel J R Janssen, Willemijn A M van Gemert, James Nagarajah
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study. Cancers 15 (1) (2022)
Manuel Weber, David Kersting, Burkhard Riemann, Tim Brandenburg, Dagmar Führer-Sakel, Frank Grünwald, Michael Christoph Kreissl, Henning Dralle, Frank Weber, Kurt Werner Schmid, Ken Herrmann, Walter Jentzen, Hong Grafe, Christoph Rischpler, Sarah Theurer, Andreas Bockisch, James Nagarajah, Wolfgang P Fendler
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Ken Kudura, Florentia Dimitriou, Daniela Mihic-Probst, Urs J Muehlematter, Tim Kutzker, Lucas Basler, Robert Foerster, Reinhard Dummer, Joanna Mangana, Lars Husmann, Irene A Burger, Michael Christoph Kreissl
Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients. Diagnostics (Basel, Switzerland) 11 (5) (2021)
Jan Wuestemann, Sebastian Hupfeld, Dennis Kupitz, Philipp Genseke, Simone Schenke, Maciej Pech, Michael Christoph Kreissl, Oliver S Grosser
Analysis of Bone Scans in Various Tumor Entities Using a Deep-Learning-Based Artificial Neural Network Algorithm-Evaluation of Diagnostic Performance. Cancers 12 (9) (2020)
Christoph Wetz, Julian Rogasch, Philipp Genseke, Imke Schatka, Christian Furth, Michael Christoph Kreissl, Henning Jann, Marino Venerito, Holger Amthauer
Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment? Diagnostics (Basel, Switzerland) 10 (9) (2020)
Elmer Jeto Gomes Ataide, Nikhila Ponugoti, Alfredo Illanes, Simone Schenke, Michael Christoph Kreissl, Michael Friebe
Thyroid Nodule Classification for Physician Decision Support Using Machine Learning-Evaluated Geometric and Morphological Features. Sensors (Basel, Switzerland) 20 (21) (2020)